Scholars Central

Conference abstractPublished 15 Aug 2011

Nanoformulated nanocarriers with modified lactoferrin for cancer and bio-distribution through MRI

Authors: Jagat R. Kanwar, Rupinder Kanwar, Ganesh Mahidhara

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: At nano scale, the fundamental and vital properties of matter can be changed, which can be used for daunting task such as oral administration of bio-macromolecules to be able to achieve sustained delivery, controlled release, target specific delivery and combinatorial therapy. Objectives : Main objective of the study was to develop, characterize and see the bio-distribution of iron saturated lactoferrin protein loaded novel ceramic nanocarriers to deliver orally and monitor these tumours MRI imaging in xenograft colon cancer. Methods and Results : In our study, we demonstrate the formulation of a novel alginate enclosed, chitosan coated ceramic anti cancer nano carriers (ACSC NC). These NC were loaded with multi-functional anti cancer bovine lactoferrin (bLf), a natural milk based protein, for improvement of intestinal absorption, in order to develop a novel platform to carry anti cancer protein and/or peptides for oral therapy. Size, morphology, internalization and release profiles of the ACSC NC under varying pH were determined. Furthermore, uptake of these NC in vitro in colon cancer cell lines was analyzed, by measuring the endocytosis and transcytosis. NCs were characterised through various physical and biological assays. Transcytosis studies indicate the transcytosis of the NC, with minimal damage to the Caco-2 cell monolayer. In conclusion, these NC can be used for future targeted protein/peptide or nucleic acid based drug delivery to treat fiddly diseases such as cancer and neurodegenerative disorders. Lf+ loaded ACSC NC significantly reduced tumour vascularity and blood flow, and increased anti-tumour cytotoxicity, tumour apoptosis and the infiltration of tumours by leukocytes. Lf+ increased the average weight of the spleens of tumourbearing mice by ~20%, accompanied by a major increase in the numbers of particular leukocyte subsets in the spleen. CD4+, CD8+, NK, IFN-γ+-expressing and dendritic cell numbers in the spleen were significantly (P<0.001) increased compared to corresponding cell numbers for mice maintained on the control diet. Lf+ bound to the intestinal epithelium and was preferentially taken up within Peyer?s patches. It increased the production of Th1 and Th2 cytokines within the intestine and tumour, including TNF, IFN-γ, as well as nitric oxide that have been reported to sensitize tumours to doxorubicin chemotherapy. Importantly, it restored both red and white peripheral blood cell numbers depleted by doxorubicin chemotherapy, potentially fortifying the mice against cancer. In summary, bLf is a potent natural adjuvant and fortifying agent for augmenting cancer chemotherapy, but needs to be saturated with iron and administered orally in Lf+ loaded ACSC NC to be effective. Bio-distribution of iron saturated lactoferrin was determined my MRI and confirmed by other imaging techniques. We also compared our results with the doxorubicin and taxol loaded ACNC-NPs. Conclusion: Taken together, our results are highly encouraging for the development of combination nano-therapeutic strategies that combine gene silencing and drug delivery to provide more potent and targeted therapeutic, especially in late and metastatic breast cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jagat R. Kanwar”
  • BylineArticles whose byline prints “Rupinder Kanwar”
  • BylineArticles whose byline prints “Ganesh Mahidhara”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels